Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Nov 1.

Published in final edited form as: Cytokine. 2019 Jul 25;123:154789. doi: 10.1016/j.cyto.2019.154789

Figure 3. — A) LX-2 cells were treated with 250 ng/mL (white bars), 1 μg/mL CCL20 (gray bars), or no treatment (NTC: black bars) for 48 hours and levels of CCL20, ACTA2, COL1A1, SERPINE1, and PLAU were measured by qPCR. B) LX-2 cells were transfected with 100 nM CCL20 siRNA for 72 hours. Black bars represent NTC and gray bars reflect cells treated with CCL20 siRNA. All experiments were performed in triplicate and data represent means ±SD. The Mann-Whitney U test was used to assess differences between conditions. *P<0.05.

Figure 3. — A) LX-2 cells were treated with 250 ng/mL (white bars), 1 μg/mL CCL20 (gray bars), or no treatment (NTC: black bars) for 48 hours and levels of CCL20, ACTA2, COL1A1, SERPINE1, and PLAU were measured by qPCR. B) LX-2 cells were transfected with 100 nM CCL20 siRNA for 72 hours. Black bars represent NTC and gray bars reflect cells treated with CCL20 siRNA. All experiments were performed in triplicate and data represent means ±SD. The Mann-Whitney U test was used to assess differences between conditions. *P<0.05.